Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone

N Engl J Med. 2023 Feb 23;388(8):766-768. doi: 10.1056/NEJMc2214862.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Intramural

MeSH terms

  • Bone Density Conservation Agents* / therapeutic use
  • Denosumab* / therapeutic use
  • Fibrous Dysplasia of Bone* / drug therapy
  • Humans
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Denosumab

Associated data

  • ClinicalTrials.gov/NCT03571191